Jundishapur Journal of Microbiology

Published by: Kowsar

Effect of Efflux Pump Inhibitor Carbonyl Cyanide 3-Chlorophenylhydrazone on the Minimum Inhibitory Concentration of Ciprofloxacin in Acinetobacter baumannii Clinical Isolates

Abdollah Ardebili 1 , 2 , Malihe Talebi 1 , 2 , Leila Azimi 2 and Abdolaziz Rastegar Lari 1 , 2 , *
Authors Information
1 Department of Microbiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, IR Iran
2 Antimicrobial Resistance Research Center, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: January 01, 2014, 7 (1); e8691
  • Published Online: January 1, 2014
  • Article Type: Research Article
  • Received: October 21, 2012
  • Revised: December 18, 2012
  • Accepted: January 27, 2013
  • DOI: 10.5812/jjm.8691

To Cite: Ardebili A, Talebi M, Azimi L, Rastegar Lari A. Effect of Efflux Pump Inhibitor Carbonyl Cyanide 3-Chlorophenylhydrazone on the Minimum Inhibitory Concentration of Ciprofloxacin in Acinetobacter baumannii Clinical Isolates, Jundishapur J Microbiol. 2014 ; 7(1):e8691. doi: 10.5812/jjm.8691.

Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Park S, Lee KM, Yoo YS, Yoo JS, Yoo JI, Kim HS, et al. Alterations of gyrA, gyrB, and parC and Activity of Efflux Pump in Fluoroquinolone-resistant Acinetobacter baumannii. Osong Public Health Res Perspect. 2011; 2(3): 164-70[DOI][PubMed]
  • 2. Alaghehbandan R, Azimi L, Rastegar Lari A. Nosocomial infections among burn patients in Teheran, Iran: a decade later. Ann Burns Fire Disasters. 2012; 25(1): 3-7[PubMed]
  • 3. Valentine SC, Contreras D, Tan S, Real LJ, Chu S, Xu HH. Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California. J Clin Microbiol. 2008; 46(8): 2499-507[DOI][PubMed]
  • 4. Spence RP, Towner KJ. Frequencies and mechanisms of resistance to moxifloxacin in nosocomial isolates of Acinetobacter baumannii. J Antimicrob Chemother. 2003; 52(4): 687-90[DOI][PubMed]
  • 5. Vila J, Ruiz J, Goni P, Jimenez de Anta T. Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii. J Antimicrob Chemother. 1997; 39(6): 757-62[PubMed]
  • 6. Hamouda A, Amyes SG. Novel gyrA and parC point mutations in two strains of Acinetobacter baumannii resistant to ciprofloxacin. J Antimicrob Chemother. 2004; 54(3): 695-6[DOI][PubMed]
  • 7. Kumar A, Schweizer HP. Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv Drug Deliv Rev. 2005; 57(10): 1486-513[DOI][PubMed]
  • 8. Higgins PG, Wisplinghoff H, Stefanik D, Seifert H. Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii. J Antimicrob Chemother. 2004; 54(4): 821-3[DOI][PubMed]
  • 9. Lin L, Ling BD, Li XZ. Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex. Int J Antimicrob Agents. 2009; 33(1): 27-32[DOI][PubMed]
  • 10. Zechini B, Versace I. Inhibitors of multidrug resistant efflux systems in bacteria. Recent Pat Antiinfect Drug Discov. 2009; 4(1): 37-50[PubMed]
  • 11. Piddock LJ. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev. 2006; 19(2): 382-402[DOI][PubMed]
  • 12. Mahamoud A, Chevalier J, Alibert-Franco S, Kern WV, Pages JM. Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy. J Antimicrob Chemother. 2007; 59(6): 1223-9[DOI][PubMed]
  • 13. Nikasa P, Abdi-Ali A, Rahmani-Badi A, Al-Hamad A. In vitro Evaluation of Proton Motive Force-Dependent Efflux Pumps Among Multidrug Resistant Acinetobacter baumannii Isolated From Patients at Tehran Hospitals. Jundishapur J Microbiol. 2013; 6(7)
  • 14. Huang L, Sun L, Xu G, Xia T. Differential susceptibility to carbapenems due to the AdeABC efflux pump among nosocomial outbreak isolates of Acinetobacter baumannii in a Chinese hospital. Diagn Microbiol Infect Dis. 2008; 62(3): 326-32[DOI][PubMed]
  • 15. Bouvet PJM, Grimont PAD. Taxonomy of the Genus Acinetobacter with the Recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov. and Emended Descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii. Int J System Bacteriol. 1986; 36(2): 228-240[DOI]
  • 16. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol. 2006; 44(8): 2974-6[DOI][PubMed]
  • 17. Farahani RK, Moniri R, Dastehgoli K. Multi-Drug Resistant Acinetobacter-Derived Cephalosporinase and OXAs-etC Genes in Clinical Specimens of Acinetobacter spp. Isolated From Teach-ing Hospital. Jundishapur J Microbiol. 2013; 6(2): 181-185
  • 18. Opazo A, Dominguez M, Bello H, Amyes SG, Gonzalez-Rocha G. OXA-type carbapenemases in Acinetobacter baumannii in South America. J Infect Dev Ctries. 2012; 6(4): 311-6[PubMed]
  • 19. Performance standards for antimicrobial susceptibility testing; Approved standard. 2010;
  • 20. Pumbwe L, Glass D, Wexler HM. Efflux pump overexpression in multiple-antibiotic-resistant mutants of Bacteroides fragilis. Antimicrob Agents Chemother. 2006; 50(9): 3150-3[DOI][PubMed]
  • 21. Wang SH, Sheng WH, Chang YY, Wang LH, Lin HC, Chen ML, et al. Healthcare-associated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care unit. J Hosp Infect. 2003; 53(2): 97-102[PubMed]
  • 22. Soroush S, Haghi-Ashtiani MT, Taheri-Kalani M, Emaneini M, Aligholi M, Sadeghifard N, et al. Antimicrobial resistance of nosocomial strain of Acinetobacter baumannii in Children's Medical Center of Tehran: a 6-year prospective study. Acta Med Iran. 2010; 48(3): 178-84[PubMed]
  • 23. Mostofi S, Mirnejad R, Masjedian F. Multi-drug resistance in Acinetobacter baumannii strains isolated from clinical specimens from three hospitals in Tehran-Iran. Afr J Microbiol Res. 2011; 5(21): 3579-3582
  • 24. Mansouri S, Razavi M, Norouzi F, Najar SG. Prevalence of β-Lactamase Production and Antimicrobial Susceptibility of Multidrug Resistant Clinical Isolates of Non-Fermenting Gram Negative Bacteria From Hospitalized Patients in Kerman/Iran. Jundishapur J Microbiol. 2012; 5(2): 405-410[DOI]
  • 25. Asadollahi P, Akbari M, Soroush S, Taherikalani M, Asadollahi K, Sayehmiri K, et al. Antimicrobial resistance patterns and their encoding genes among Acinetobacter baumannii strains isolated from burned patients. Burns. 2012; 38(8): 1198-1203[DOI]
  • 26. Wei-feng S, Jian-ping J, Ning X, Zhi-mi H, Yu-yue W. Inhibitory effects of reserpine and carbonyl cyanide m3chloro3 phenylhydrazone on fluoroquinolone resistance of <italic>Acinetobacter baumannii</italic> Chin Med J. 2005; 118(4): 340-43
  • 27. Rajamohan G, Srinivasan VB, Gebreyes WA. Novel role of Acinetobacter baumannii RND efflux transporters in mediating decreased susceptibility to biocides. J Antimicrob Chemother. 2010; 65(2): 228-32[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments